The present invention relates to novel selective binding agents including polyclonal and monoclonal antibodies that recognize and bind to the catalytic subunit of human telomerase (hTERT). The invention also relates to the production, diagnostic use, and therapeutic use of the hTERT antibodies and fragments thereof.

 
Web www.patentalert.com

< Arylsulfonamidobenzylic compounds

< Kinase inhibitors

> Antibodies to cyclin E2 protein

> Metalloproteinase inhibitor

~ 00276